These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
329 related items for PubMed ID: 12254979
1. Thromboembolic disease and the steroidal content of oral contraceptives. Swyer GI. Res Reprod; 1970 Jul; 2(4):1. PubMed ID: 12254979 [Abstract] [Full Text] [Related]
2. Oestriol deficiency, a possible factor in the aetiology of thrombo-embolism in pill users. Zaki K, Sami G, Nour H. Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):19-24. PubMed ID: 12256026 [Abstract] [Full Text] [Related]
3. Newer synthetic progestins for the treatment of endometriosis. Kistner RW. Prog Gynecol; 1970 Jun; 5():283-302. PubMed ID: 12332429 [Abstract] [Full Text] [Related]
5. [Cardiovascular risks of oral contraceptives: dose-response relationship]. Kelleher CC. Contracept Fertil Sex (Paris); 1991 Apr; 19(4):285-8. PubMed ID: 12343220 [Abstract] [Full Text] [Related]
6. [Influence of progestins on adverse effects of oral contraceptives]. Wynn V. Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210 [Abstract] [Full Text] [Related]
7. The choice of the dose of oestrogen in a combined oral contraceptive. Smith M. Fertil Contracept; 1978 Apr; 2(2):22-3. PubMed ID: 12336093 [Abstract] [Full Text] [Related]
8. [Veins and contraception]. Reinharez D, Monsonego J. Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):131-6. PubMed ID: 12280199 [Abstract] [Full Text] [Related]
9. Liver function tests in patients on oral progestogens. Engineer AD, Gupta V, Tandon P. J Obstet Gynaecol India; 1968 Apr; 18(2):598-605. PubMed ID: 12331828 [Abstract] [Full Text] [Related]
11. Estrogen dose in oral contraceptives: FDA committee examines safety and utility of 50 mcg estrogen OCs. Contracept Rep; 1994 Mar; 5(1):10-3. PubMed ID: 12287738 [Abstract] [Full Text] [Related]
12. [Oral contraception: evolution of concepts over the last thirty years]. Belaisch J, Hommais-loufrani B. Contracept Fertil Sex (Paris); 1987 Nov; 15(11 Suppl):1-8. PubMed ID: 12281408 [Abstract] [Full Text] [Related]
16. Thromboembolic disease and the steroidal content of oral contraceptives. A report to the Committee on Safety of Drugs. Inman WH, Vessey MP, Westerholm B, Engelund A. Br Med J; 1970 Apr 25; 2(5703):203-9. PubMed ID: 5443406 [Abstract] [Full Text] [Related]
17. Estrogens: why harmless as menopausal therapy but hazardous in the "Pill"? Edwards CC, Drill VA. JAMA; 1971 Jan 18; 215(3):(3): 492-493. PubMed ID: 12332746 [Abstract] [Full Text] [Related]
18. [Potential advantages of triphasic combined oral contraceptives in the light of recent epidemiological and endocrinometabolic data]. Gaspard U, Dubois M. Contracept Fertil Sex (Paris); 1982 Sep 18; 10(9):551-60. PubMed ID: 12311606 [Abstract] [Full Text] [Related]
19. [Oral contraceptives and blood platelets]. Davenas E, Ciavatti M, Poitevin B, Aubin M. Homeopath Fr; 1985 Sep 18; 73(5):299-305. PubMed ID: 12281246 [Abstract] [Full Text] [Related]
20. Action of hormonal contraceptives on the coagulation system and some of its inhibitors. Misz M, Beck P. Acta Med Hung; 1986 Sep 18; 43(3):301-10. PubMed ID: 2438639 [Abstract] [Full Text] [Related] Page: [Next] [New Search]